drug,predicted_response_rate,observed_literature_response_rate
Gefitinib,2,6
Cisplatin,58,60
Doxorubicin,5,20
Docetaxel,36,28
Paclitaxel,56,75
Carboplatin,75,75
Gemcitabine,58,47
